Ioanna I. Koukli PhD, has more than 30 years of experience in health innovation. Through a career track of over a decade in the Pharmaceutical Industry reaching the position of R&D Manager, Dr. Koukli establishes Pharmassist Ltd in 1999, a leading Contract Research Organization in Greece.
She has always been active in the Pharmaceutical Science Industry serving in many policy making committees advocating for health innovation and has developed extensive expertise and “know-how” on developing new health technologies, the promotion of translational research and accessing new markets on a global scale.
In 2014, on her own personal initiative, the Research and Development department of Pharmassist is created, and in collaboration with the Analysis of Circulating Tumor Cells Laboratory (ACTC Lab) of the Department of Chemistry of the National and Kapodistrian University of Athens, the company launches into the development and commercialization of CE in-vitro diagnostic products in the field of oncology, in privately-owned state-of-the-art laboratories.
Since November 2019, and for a second consecutive term, Dr. Koukli has been Presiding the Hellenic BioCluster. She has also been an elected member of the Administrative Board of the Hellenic Society of Pharmaceutical Medicine (ELEFI) for two consecutive terms. In 2011 she was invited to the United States under the auspices of the Department of State's International Visitor Leadership Program, as a representative of Greek female entrepreneurship.
Dr. Koukli holds a BSc and a PhD in Chemistry, both awarded by the Department of Chemistry at the National and Kapodistrian University of Athens.